The organ preservation market was USD 243.7 million in 2022, and it will reach USD 442.6 million, propelling at a 7.7% compound annual growth rate by 2030.
 |
| To learn more about this report: https://bit.ly/47EJtZz |
Organ preservation industry growth is significantly influenced by the rising incidence of multiple organ failure. Multi-organ failure occurs when many key organs in the body are unable to operate properly, frequently as a result of serious illnesses or major accidents.
To give patients with multi-organ failure a chance at survival and better quality of life, organ transplantation becomes a significant therapy option.
A key factor in the growth of the organ preservation market is the rise in organ transplants and organ donors. Technology advancements in organ preservation are crucial in assisting the growing number of organ transplants. Before transplantation and during transit, these technologies guarantee that donated organs are healthy and functional.
North America held the largest industry share of 45% in 2022, and it is expected to show significant growth by 2030.
The healthcare system in North America is well-established and sophisticated, with cutting-edge hospitals, research institutes, and transplant centers. This area's supremacy in the industry is a result of the efficient organ preservation, transplantation, and post-transplant care made possible by the region's strong healthcare system.
End-stage organ failure, including kidney, liver, heart, and lung failure, is extremely common in the region. As a result, there is a significant need for organ transplantation and technologies for organ preservation are essential in satisfying this need.
The growth of the global organ preservation industry is mainly driven by the increasing elderly population and rising incidence of multiple organ failure, necessitating organ transplantation as a significant therapy option.
